Skip to main content
. 2020 Dec 26;26:e928185-1–e928185-26. doi: 10.12659/MSM.928185

Supplementary Table 1.

Clinical information for 102 patients with laryngeal squamous cell carcinoma.

Sample ID of patients Age Gender Grade Stage Tumor stage Nodes stage Risk score
TCGA-BA-4076-01 <65 Male G1–2 Stage III–IV T3–4 N2–3 1.994791
TCGA-BA-4078-01 ≥65 Male G1–2 Stage III–IV T1–2 N2–3 7.175697
TCGA-BA-5555-01 <65 Male G1–2 Stage III–IV T1–2 N2–3 0.613095
TCGA-BA-6868-01 <65 Male G1–2 Stage III–IV T3–4 N2–3 9.846364
TCGA-BA-6869-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 1.212306
TCGA-BA-6870-01 <65 Female G1–2 Stage III–IV T3–4 N2–3 2.463018
TCGA-BA-A6DA-01 <65 Female G1–2 Stage III–IV T3–4 N2–3 0.180343
TCGA-BA-A6DI-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 4.540384
TCGA-BB-4217-01 ≥65 Male G3 Stage III–IV T3–4 N2–3 0.479486
TCGA-CN-4722-01 <65 Female G1–2 Stage I–II T1–2 N0–1 0.391675
TCGA-CN-4723-01 ≥65 Male G1–2 Stage III–IV T3–4 N0–1 1.676743
TCGA-CN-4727-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 0.858521
TCGA-CN-4735-01 <65 Male G3 Stage III–IV T3–4 N2–3 1.057629
TCGA-CN-4738-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 1.380504
TCGA-CN-4739-01 ≥65 Male G1–2 Stage III–IV T3–4 N0–1 0.209937
TCGA-CN-5355-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 1.015923
TCGA-CN-5356-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 0.22631
TCGA-CN-5360-01 ≥65 Male G1–2 Stage III–IV T3–4 N0–1 0.150048
TCGA-CN-5363-01 <65 Male G3 Stage III–IV T3–4 N2–3 1.581695
TCGA-CN-6010-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 0.485192
TCGA-CN-6012-01 ≥65 Male G1–2 Stage III–IV T3–4 N0–1 0.698411
TCGA-CN-6021-01 <65 Female G1–2 Stage III–IV T3–4 N0–1 7.842248
TCGA-CN-6022-01 <65 Male G3 Stage III–IV T3–4 N0–1 2.948932
TCGA-CN-6988-01 <65 Male G3 Stage III–IV T3–4 N2–3 0.143416
TCGA-CN-6989-01 <65 Male G1–2 Stage III–IV T3–4 N2–3 4.86375
TCGA-CN-6992-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 0.676387
TCGA-CN-6997-01 ≥65 Male G3 Stage III–IV T3–4 N2–3 1.203079
TCGA-CN-A497-01 <65 Male G1–2 Stage III–IV T1–2 N2–3 0.070669
TCGA-CN-A49B-01 ≥65 Male G3 Stage III–IV T3–4 N0–1 2.197291
TCGA-CN-A63T-01 <65 Male G3 Stage III–IV T3–4 N2–3 1.399677
TCGA-CN-A63U-01 <65 Male G3 Stage III–IV T3–4 N0–1 0.641362
TCGA-CN-A63W-01 <65 Female G1–2 Stage III–IV T3–4 N2–3 2.018491
TCGA-CN-A641-01 <65 Male G1–2 Stage III–IV T3–4 N2–3 1.561376
TCGA-CN-A6V3-01 <65 Male G3 Stage III–IV T3–4 N2–3 0.086898
TCGA-CR-6474-01 <65 Male G1–2 Stage III–IV T3–4 N2–3 9.085744
TCGA-CR-7364-01 ≥65 Male G1–2 Stage III–IV T3–4 N0–1 1.727247
TCGA-CR-7370-01 ≥65 Female G1–2 Stage I–II T1–2 N0–1 2.24474
TCGA-CR-7371-01 <65 Female G1–2 Stage III–IV T3–4 N0–1 3.987309
TCGA-CR-7374-01 ≥65 Female G1–2 Stage I–II T1–2 N0–1 2.598793
TCGA-CR-7388-01 ≥65 Female G1–2 Stage III–IV T1–2 N2–3 2.350348
TCGA-CR-7389-01 <65 Male G1–2 Stage III–IV T1–2 N0–1 1.464127
TCGA-CR-7398-01 <65 Female G1–2 Stage I–II T1–2 N0–1 1.308124
TCGA-CR-7399-01 <65 Female G3 Stage III–IV T3–4 N2–3 0.832214
TCGA-CR-7402-01 ≥65 Male G1–2 Stage III–IV T3–4 N0–1 0.304261
TCGA-CV-5430-01 <65 Male G3 Stage III–IV T3–4 N2–3 0.323973
TCGA-CV-5431-01 ≥65 Male G3 Stage III–IV T3–4 N2–3 0.58173
TCGA-CV-5432-01 ≥65 Male G3 Stage III–IV T3–4 N0–1 0.455714
TCGA-CV-5434-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 0.572978
TCGA-CV-5435-01 <65 Male G3 Stage III–IV T3–4 N0–1 0.822588
TCGA-CV-5440-01 <65 Male G3 Stage III–IV T3–4 N2–3 0.576644
TCGA-CV-5441-01 <65 Male G3 Stage III–IV T3–4 N0–1 0.028728
TCGA-CV-5443-01 <65 Male G3 Stage III–IV T3–4 N0–1 0.148582
TCGA-CV-5444-01 <65 Male G3 Stage III–IV T3–4 N0–1 0.209379
TCGA-CV-5978-01 <65 Female G1–2 Stage III–IV T3–4 N2–3 3.792788
TCGA-CV-6935-01 ≥65 Male G3 Stage III–IV T3–4 N0–1 1.824833
TCGA-CV-6962-01 ≥65 Male G1–2 Stage III–IV T3–4 N0–1 9.405468
TCGA-CV-7089-01 ≥65 Male G1–2 Stage III–IV T3–4 N2–3 0.886302
TCGA-CV-7101-01 ≥65 Male G1–2 Stage I–II T1–2 N0–1 1.524558
TCGA-CV-7177-01 ≥65 Female G1–2 Stage I–II T1–2 N0–1 14.47409
TCGA-CV-7242-01 <65 Female G1–2 Stage III–IV T3–4 N0–1 0.393045
TCGA-CV-7245-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 7.160395
TCGA-CV-7247-01 <65 Male G1–2 Stage I–II T1–2 N0–1 1.302915
TCGA-CV-7248-01 <65 Female G1–2 Stage III–IV T3–4 N2–3 5.899374
TCGA-CV-7250-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 0.765147
TCGA-CV-7261-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 0.778688
TCGA-CV-7415-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 2.108499
TCGA-CV-7418-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 5.986007
TCGA-CV-7421-01 ≥65 Male G1–2 Stage III–IV T3–4 N0–1 12.39132
TCGA-CV-7422-01 <65 Female G3 Stage III–IV T3–4 N0–1 1.383207
TCGA-CV-7424-01 ≥65 Male G1–2 Stage III–IV T3–4 N2–3 1.60996
TCGA-CV-7430-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 16.21789
TCGA-CV-7433-01 <65 Male G3 Stage III–IV T3–4 N0–1 7.315585
TCGA-CV-A45W-01 ≥65 Male G1–2 Stage III–IV T3–4 N0–1 0.269141
TCGA-CV-A45Y-01 <65 Male G3 Stage III–IV T3–4 N0–1 0.689461
TCGA-CV-A45Z-01 ≥65 Male G3 Stage I–II T1–2 N0–1 0.854492
TCGA-CV-A460-01 ≥65 Male G3 Stage III–IV T3–4 N2–3 0.546034
TCGA-CV-A461-01 ≥65 Male G1–2 Stage III–IV T3–4 N0–1 0.546608
TCGA-CV-A6K1-01 ≥65 Male G1–2 Stage III–IV T3–4 N0–1 0.360293
TCGA-D6-6517-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 0.68767
TCGA-D6-6824-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 0.495199
TCGA-D6-6826-01 <65 Female G1–2 Stage III–IV T3–4 N2–3 1.514392
TCGA-D6-8568-01 <65 Male G1–2 Stage I–II T1–2 N0–1 0.417747
TCGA-D6-A6EK-01 ≥65 Male G1–2 Stage III–IV T3–4 N0–1 0.189092
TCGA-D6-A6EQ-01 <65 Male G3 Stage III–IV T3–4 N0–1 0.545436
TCGA-D6-A6ES-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 0.191914
TCGA-D6-A74Q-01 ≥65 Male G3 Stage III–IV T3–4 N0–1 0.22864
TCGA-DQ-5629-01 <65 Male G1–2 Stage III–IV T3–4 N2–3 2.062312
TCGA-F7-7848-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 0.690225
TCGA-F7-8298-01 <65 Male G1–2 Stage I–II T1–2 N0–1 0.30976
TCGA-KU-A66S-01 ≥65 Female G1–2 Stage III–IV T1–2 N0–1 4.15964
TCGA-QK-A8Z8-01 <65 Female G1–2 Stage III–IV T3–4 N0–1 0.330232
TCGA-QK-A8ZB-01 v65 Male G1–2 Stage III–IV T3–4 N0–1 1.588431
TCGA-QK-AA3J-01 ≥65 Male G3 Stage I–II T1–2 N0–1 0.419213
TCGA-T3-A92M-01 <65 Male G1–2 Stage III–IV T3–4 N2–3 3.215592
TCGA-UF-A718-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 0.79612
TCGA-UF-A71D-01 <65 Female G1–2 Stage III–IV T3–4 N0–1 0.063101
TCGA-UF-A7J9-01 ≥65 Male G1–2 Stage III–IV T3–4 N0–1 3.368041
TCGA-UF-A7JF-01 ≥65 Male G1–2 Stage III–IV T3–4 N2–3 0.350744
TCGA-UF-A7JH-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 0.220921
TCGA-UF-A7JJ-01 ≥65 Male G1–2 Stage III–IV T3–4 N0–1 0.834466
TCGA-UF-A7JK-01 <65 Male G1–2 Stage III–IV T3–4 N0–1 1.902253

Grade – neoplasm histologic grade.